NephroPath Company Profile
Time to diagnosis can have a critical effect on the ultimate outcome of many renal diseases, and when a patient undergoes an invasive procedure such as a renal biopsy, there can be significant anxiety while the results are pending. Over the last 14 years, Dr. Patrick Walker, our Director and one of the nation's leading renal pathologists, has developed a unique system for rapid processing of renal biopsies that has enabled NephroPath to become one of the nation's largest renal biopsy practices, receiving biopsies from more than 300 nephrologists coast to coast.
10810 Executive Center DriveSuite 100
United States of America
Drugs and Medications
Autoantibody formation directed against phospholipase A2 receptor (PLA2R)1 is the underlying etiology in most cases of primary membranous glomerulopathy. This new understanding of the pathogenesis of...
Time to diagnosis can have a critical effect on the ultimate outcome of many renal diseases, and when a patient undergoes an invasive procedure such as a renal biopsy, there can be significant anxiety...
More Information about "NephroPath" on BioPortfolio
We have published hundreds of NephroPath news stories on BioPortfolio along with dozens of NephroPath Clinical Trials and PubMed Articles about NephroPath for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NephroPath Companies in our database. You can also find out about relevant NephroPath Drugs and Medications on this site too.